European Healthtech startup funding raised during Q1 2026.
In Q1 2026, 132 European Healthtech companies raised a combined €1.6B across 133 funding rounds, down 36.9% versus Q1 2025. UK led by capital raised, and BioInnovation Institute was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Oviva | Series D+ | Jan 2026 | €200M |
| Alvotech | Debt | Jan 2026 | €100M |
| DentalMonitoring | Other | Feb 2026 | €71M |
| Neurent Medical | Series C | Feb 2026 |
8 exits · €469M disclosed.
| Kaia Health | Acquisition | Jan 2026 | €239M |
| Gleamer | Acquisition | Mar 2026 | €230M |
| €63M |
| Vitestro | Series B | Mar 2026 | €60M |
| Exciva | Series B | Jan 2026 | €51M |
| FineHeart | Grant | Jan 2026 | €48M |
| Biorce | Series A | Feb 2026 | €44M |
| Polares Medical | Series C | Mar 2026 | €43M |
| bit.bio | Other | Jan 2026 | €43M |
| Automata Technologies | Series C | Jan 2026 | €38M |
| Recare Solutions | Other | Jan 2026 | €37M |
| FineHeart | Series C | Jan 2026 | €35M |
| Centauri | Series A | Feb 2026 | €34M |
| Aerska | Series A | Feb 2026 | €33M |
